[The serotonin syndrome]
Related Experiment Video
Updated: Nov 2, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
L Broude1, I Iancu, O T Dolberg
1Psychiatric Division, Chaim Sheba Medical Center, Tel Hashomer.
Abstract:
The frequent use of selective, serotonin reuptake inhibitors has increased the risk of the serotonin syndrome. This condition is related to stimulation of 5HT1A receptors and is characterized by agitation, confusion, tremor, fever and shivering. A 29-year-old woman and a 69-year-old man with the syndrome are reported. The importance of early diagnosis and treatment is emphasized, and aspects of the syndrome in patients with obsessive-compulsive disorder are presented.
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Toxidromes: Clinical Features
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Drug toxicity: Idiosyncratic Reactions
